EUVIMEDEUVIMED entdecken
Crossref

Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities

Lihua Zhao, Bingbing Li, Lin Zheng iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Lihua Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Energy and Chemical Engineering, Tianjin Renai College, Tianjin, 301636, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Cholinesterase Inhibitors, Drug Design, Coordination Complexes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is multifactorial, which makes the design of multi‐target‐directed ligands an attractive strategy for the development of anti‐AD drugs. In order to enhance the anti‐AD effects and reduce the toxicity, two usnic acid (UA) derivatives ( 1–2 ) were designed, synthesized and fully characterized by introducing dimethylamine Schiff base moiety into the toxic “triketone” portion. Ellman's method and molecular docking were used to test the cholinesterase inhibitory activities. Antioxidant activities were studied with Fenton reaction, cyclic voltammetry and C. elegans . The results showed that compared with UA, 1–2 had stronger anti‐cholinesterase activities and similar antioxidant activities. Notably, solvent evaporation of 2 and ZnCl 2 formed a single crystal, which was revealed to be a Zn(II) complex with UA and tertiary amine as mixed ligands by X‐ray diffraction. The hydrolysis of 2 was thus furtherly studied by HPLC. Furthermore, the crystal structure supported the replacement of toxic “triketone” moiety in the chelation process, playing a detoxifying role and at the same time regulating metal homeostasis. In silico prediction also showed low hepatotoxicity and acceptable drug‐likeness of 1–2 . Overall, this work provided useful insights into multi‐target anti‐AD candidates with the natural product UA as the lead compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCholinesterase InhibitorsDrug DesignCoordination ComplexesZincBenzofuransCrystallography, X-RayAnimalsMolecular Docking SimulationAntioxidantsCaenorhabditis elegansHumansMolecular StructureAcetylcholinesteraseStructure-Activity Relationship

Stichwörter der Autor:innen

Alzheimer's diseaseMetal homeostasisMulti-target-directed ligands (MTDLs)Usnic acidX-ray single crystal diffraction

Substanzen

Cholinesterase InhibitorsCoordination ComplexesZincusnic acidBenzofuransAntioxidantsAcetylcholinesterase

Autor:innen und Institutionen

  • School of Energy and Chemical Engineering, Tianjin Renai College, Tianjin, 301636, China.
  • College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.

ORCID-Profile: Lin Zheng

Zitieren

APA

Zhao, L., Li, B., & Zheng, L. (2025). Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401548

Vancouver

Zhao L, Li B, Zheng L. Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401548

BibTeX
@article{Zhao2025,
  author = {Zhao, Lihua and Li, Bingbing and Zheng, Lin},
  title = {Usnic Acid Derivatives as Multi‐Target Anti‐Alzheimer's Disease Agents: Design, Synthesis, X‐Ray Single Crystal Structure of Zn(II) Complex and Biological Activities},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401548}
}
Kostenlos starten →